reference/21402402

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21402402

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	848
issn	1083-7159 1549-490X
issueIdentifier	7
pageRange	841-848
publicationName	The Oncologist
startingPage	841
bibliographicCitation	Cartenì G, Bordonaro R, Giotta F, Lorusso V, Scalone S, Vinaccia V, Rondena R, Amadori D. Efficacy and safety of zoledronic acid in patients with breast cancer metastatic to bone: a multicenter clinical trial. Oncologist. 2006 Jul;11(7):841–8. doi: 10.1634/theoncologist.11-7-841. PMID: 16880243.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4647-0919 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b32e34b7dc1a55d5a2eef8fa58942a19 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9028719e115a5090cc806846162dadf9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_255de012f0367c37a025acd9c894af2d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7476bc00fcaad42c415baa914cda2a85 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1441-6376 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c3046766e48e34719d5254e81f292ec9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_be91994eb49613bc1e7e6813761fac5d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_99b6da8f55bf72ffe67e57f0a2f0dddc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_47512d3f3e807561719348bad4416c14
date	2006-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1634/theoncologist.11-7-841 https://pubmed.ncbi.nlm.nih.gov/16880243
isPartOf	https://portal.issn.org/resource/ISSN/1549-490X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21392 https://portal.issn.org/resource/ISSN/1083-7159
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Efficacy and Safety of Zoledronic Acid in Patients with Breast Cancer Metastatic to Bone: A Multicenter Clinical Trial
discusses	http://id.nlm.nih.gov/mesh/M0234600 http://id.nlm.nih.gov/mesh/M0006519 http://id.nlm.nih.gov/mesh/M0472480 http://id.nlm.nih.gov/mesh/M0011048
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D004164Q000627 http://id.nlm.nih.gov/mesh/D007093Q000627 http://id.nlm.nih.gov/mesh/D001943Q000188 http://id.nlm.nih.gov/mesh/D050071Q000627 http://id.nlm.nih.gov/mesh/D001859Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D007262 http://id.nlm.nih.gov/mesh/D004164Q000009 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D001943Q000473 http://id.nlm.nih.gov/mesh/D000077211 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D007093Q000009 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D001859Q000556 http://id.nlm.nih.gov/mesh/D050071Q000009 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D005260
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9269 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64747 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68740 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8756 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8063 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7732 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10907 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID588

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129728658

Total number of triples: 69.